Volunteers prepared doses of the Moderna COVID-19 vaccine at Forand Manor in Central Falls, RI on December 30, 2020.
The Boston Globe | The Boston Globe | Getty Images
European Medicines Agency On Wednesday, the Coronavirus vaccine Moderna recommended for use in the European UnionAnd the at the time Criticism is growing about the slow rolling out of punches across the block.
“The EMA Human Medicines Committee comprehensively evaluated the data on vaccine quality, safety and efficacy and unanimously recommended the granting of an official conditional marketing authorization by the European Commission,” the association said in a statement.
Emer Koc, Executive Director of the Amsterdam-based EMA, added that the Moderna vaccine “provides us with another tool to overcome the current emergency.” It paves the way for the European Commission, the executive arm of the European Union, to follow suit.
Moderna is the second green lit vaccine by European regulators, but vaccinations have already begun to be distributed in the United Kingdom and the United States, where they were approved earlier.
Some lawmakers have expressed concern that the European Union is too slow to distribute coronavirus vaccines among its citizens.
The spread of Covid-19 vaccines varies across the cluster. France reported 516 vaccines in the first week of its launch, while Germany had carried about 240,000 vaccines as of Sunday. The Netherlands has yet to start vaccinating people against the Coronavirus.
Additionally, there are also questions about whether the European Union has purchased enough vaccines.
A number of officials have asked the European Commission, the executive arm of the European Union, to explain why it is not buying more punches.
On Monday, a European Commission spokesperson said the institution was “very focused on ensuring that our strategy is well implemented.”
Moderna shares rose slightly in pre-market trading on the back of the announcement.